Lataa...
Intracellular targeting with engineered proteins
If the isolation, production, and clinical use of insulin marked the inception of the age of biologics as therapeutics, the convergence of molecular biology and combinatorial engineering techniques marked its coming of age. The first wave of recombinant protein-based drugs in the 1980s demonstrated...
Tallennettuna:
| Julkaisussa: | F1000Res |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
F1000Research
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4984483/ https://ncbi.nlm.nih.gov/pubmed/27547383 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.8915.1 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|